Skip to main content
SpringerLink
Log in

Neuropsychological Outcomes in Children with Acute Lymphoblastic Leukemia

  • Chapter
Handbook of Long Term Care of The Childhood Cancer Survivor

Part of the book series: Specialty Topics in Pediatric Neuropsychology ((STPN))

Abstract

Acute Lymphoblastic Leukemia (ALL) and related blood cancers are the most common malignancy diagnosed in children. Mortality rates have declined significantly in the past several decades with advances in treatment approaches, including chemotherapeutic agents and cranial radiation, and approximately 80–85 % of children with leukemia are now surviving beyond 5 years post-diagnosis. Due to the increased survival rate, children are now facing many late effects following treatment, including cognitive dysfunction. There are many factors that are associated with increased risk for cognitive late effects. This chapter will provide a comprehensive review of the literature, addressing the various treatment protocols that are associated with increased risk for these cognitive late effects, and will examine the role of cranial radiation, chemotherapy, and glucocorticoids on the developing brain. Specific functions, such as intelligence, academic functioning, attention, sensorimotor, visual-motor, visual-spatial, executive function, and memory, have all been shown to be differentially impacted and are dependent upon several different variables currently known, including types and method of delivery of chemotherapeutic agents, dosage of cranial radiation, and uses of glucocorticoids. Furthermore, we will discuss individual variables, such as gender, age, and premorbid level of functioning, that research has identified as influencing cognitive morbidity. A case presentation will provide the reader with an example of how these variables might manifest, and how neuropsychological evaluation and neuroimaging can provide valuable data to help guide treatment planning for long-term follow-up of the childhood cancer survivor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society. (2011). Cancer facts and figures. Accessed December 15, 2012, from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf

  2. SEER (Surveillance, Epidemiology and End Results). (2011). Cancer statistics review, 1975–2008. National Cancer Institute.

    Google Scholar 

  3. Esparza, S., & Sakamoto, K. (2005). Topics in pediatric leukemia – acute lymphoblastic leukemia. Medscape General Medicine, 7, 23.

    PubMed Central  PubMed  Google Scholar 

  4. Leukemia and Lymphoma Society. (2012). Facts. Accessed December 21, 2012, from http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/generalcancer/pdf/facts.pdf

  5. Woodruff, T. J., Axelrad, D. A., Kyle, A. D., Nweke, O., Miller, G. G., & Hurley, B. J. (2004). Trends in environmentally related childhood illnesses. Pediatrics, 113, 1133–1140.

    PubMed  Google Scholar 

  6. Pui, C. H., Chessells, J. M., Camitta, B., et al. (2003). Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia, 17(4), 700–706.

    PubMed  Google Scholar 

  7. National Center for Health Statistics. (2005). Vital statistics, instructions for classifying the underlying causes of death: NCHS instruction manual: Part 2a. Accessed December 31, 2012, from http://www.cdc.gov/nchs/data/dvs/2a2005a.pdf

  8. Jemal, A., Clegg, L. X., Ward, E., et al. (2004). Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer, 101(1), 3–27.

    PubMed  Google Scholar 

  9. Matloub, Y., Angiolillo, A., Bostrom, B., et al. (2006). Double delayed intensification is equivalent to single DI in children with National Cancer Institute standard-risk acute lymphoblastic leukemia treated on Children’s Cancer Group Clinical Trial 1991 (CCG 1991). American Society of Hematology Annual Meeting Abstracts, 108, 146.

    Google Scholar 

  10. Pui, C. H., Robinson, L. L., & Look, A. T. (2008). Acute lymphoblastic leukemia. Lancet, 371(9617), 1030–1043.

    PubMed  Google Scholar 

  11. Ellinghaus, E., Stanulla, M., Richter, G., Ellinghaus, D., te Kronnie, G., Cario, G., et al. (2012). Identification of germline susceptibility loci inETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia, 26, 902–909.

    PubMed Central  PubMed  Google Scholar 

  12. Belson, M., Kingsley, B., & Holmes, A. (2007). Risk factors for acute leukemia in children: A review. Environmental Health Perspectives, 115, 138–145.

    PubMed Central  PubMed  Google Scholar 

  13. Eden, T. (2010). Aetiology of childhood leukemia. Cancer Treatment Reviews, 36, 286–297.

    PubMed  Google Scholar 

  14. Fong, C. T., & Brodeur, G. M. (1987). Down’s syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics, 28(1), 55–76.

    PubMed  Google Scholar 

  15. Papaemmanuil, E., Hosking, F. J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., et al. (2009). Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nature Genetics, 41, 1006–1010.

    PubMed  Google Scholar 

  16. Trevino, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., et al. (2009). Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nature Genetics, 41, 1001–1005.

    PubMed Central  PubMed  Google Scholar 

  17. Binsky, I., Lantner, F., Grabovsky, V., Harpaz, N., Shvidel, L., Berrebi, A., et al. (2010). TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner. Journal of Immunology, 184, 4761–4769.

    Google Scholar 

  18. Mita, Y., Yasuda, Y., Sakai, A., Yamamoto, H., Toyooka, S., Gunduz, M., et al. (2010). Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. Journal of Cancer Research and Clinical Oncology, 136, 249–259.

    PubMed  Google Scholar 

  19. Reaman, G. H. (2002). Pediatric oncology: Current views and outcomes. Pediatric Clinics of North America, 49, 1305–1318.

    PubMed  Google Scholar 

  20. Shumacher, H. R. (2002). Acute leukemia. Clinics in Laboratory Medicine, 22, 153–192.

    Google Scholar 

  21. Anderson, V., Smibert, E., Ekert, H., & Godber, T. (1994). Intellectual, educational, and behavioral sequelae after cranial irradiation and chemotherapy. Archives of Disease in Childhood, 70, 476–485.

    PubMed Central  PubMed  Google Scholar 

  22. Espy, K., Moore, I., Kaufmann, P., et al. (2001). Chemotherapeutic CNS prophylaxis and neuropsychological change in children with acute lymphoblastic leukemia: A prospective study. Journal of Pediatric Psychology, 26, 1–91.

    PubMed  Google Scholar 

  23. Brown, R., Sawyer, M., Antoniou, G., et al. (1999). Longitudinal follow-up of the intellectual and academic functioning of children receiving central nervous system-prophylactic chemotherapy for leukemia: A four-year final report. Journal of Developmental and Behavioral Pediatrics, 20, 373–377.

    PubMed  Google Scholar 

  24. Waber, D. P., Shapiro, B. L., Carpentieri, S. C., et al. (2001). Excellent therapeutic efficiency and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: A 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87–01. Cancer, 91, 1.

    Google Scholar 

  25. Kingma, A., Van Dommelen, R. I., Mooyaart, E. L., Wilmink, J. T., Deelman, B. G., & Kamps, W. A. (2002). No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: A prospective longitudinal study. Journal of Pediatric Hematology/Oncology, 24(2), 106–114.

    PubMed  Google Scholar 

  26. Cousens, P., Waters, B., Said, J., & Stevens, M. (1988). Cognitive effects of cranial irradiation in leukemia: A survey and meta-analysis. Journal of Child Psychology and Psychiatry, 29(6), 839–852.

    PubMed  Google Scholar 

  27. Brouwers, P., Riccardi, R., Fedio, P., & Poplack, G. (1985). Long term neuropsychologic sequelea of childhood leukemia. Correlation with CT brain scan abnormalities. Journal of Pediatrics, 106(5), 723–728.

    PubMed  Google Scholar 

  28. Waber, D. (2002). More good news about neuropsychological late effects in long-term survivors of acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 24(2), 86–87.

    PubMed  Google Scholar 

  29. Nathan, P. C., Patel, S. K., Dilley, K., et al. (2007). Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the children’s oncology group. Archives of Pediatrics & Adolescent Medicine, 161(8), 798–806.

    Google Scholar 

  30. Möricke, A., Zimmermann, M., Reiter, A., et al. (2005). Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: Data from the trials ALL-BFM 86, 90, and 95. Klinische Pädiatrie, 217(6), 310–320.

    PubMed  Google Scholar 

  31. Reaman, G. H., Sposto, R., Sensel, M. G., et al. (1999). Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the children’s cancer group. Journal of Clinical Oncology, 17(2), 445–455.

    PubMed  Google Scholar 

  32. Kosaka, Y., Koh, K., Kinukawa, N., et al. (2004). Infant acute lymphoblastic leukemia with MLL gene rearrangements: Outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood, 104(12), 3527–3534.

    PubMed  Google Scholar 

  33. Pieters, R., Schrappe, M., De Lorenzo, P., et al. (2007). A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (interfant-99): An observational study and a multicentre randomized trial. Lancet, 370(9583), 240–250.

    PubMed  Google Scholar 

  34. Smith, M., Arthur, D., Camitta, B., et al. (1996). Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 14(1), 18–24.

    PubMed  Google Scholar 

  35. Bürger, B., Zimmermann, M., Mann, G., et al. (2003). Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture. Journal of Clinical Oncology, 21(2), 184–188.

    PubMed  Google Scholar 

  36. Swerdlow, S. H., Campo, E., Harris, N. L., et al. (Eds.). (2008). WHO classification of tumours of hematopoietic and lymphoid tissues (4th ed.). Lyon, France: International Agency for Research on Cancer.

    Google Scholar 

  37. Möricke, A., Ratei, R., Ludwig, W.D., et al. (2004). Prognostic factors in CD10 negative precursor b-cell acute lymphoblastic leukemia in children: Data from three consecutive trials ALL-BFM 86, 90, and 95. Blood, 104(11):A-1957, 540a.

    Google Scholar 

  38. Schrappe, M., Reiter, A., Ludwig, W. D., et al. (2000). Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 95(11), 3310–3322.

    PubMed  Google Scholar 

  39. Goldberg, J. M., Silverman, L. B., Levy, D. E., et al. (2003). Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber cancer institute acute lymphoblastic leukemia consortium experience. Journal of Clinical Oncology, 21(19), 3616–3622.

    PubMed  Google Scholar 

  40. Silverman, L. B., Gelber, R. D., Dalton, V. K., et al. (2001). Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber consortium protocol 91–01. Blood, 97(5), 1211–1218.

    PubMed  Google Scholar 

  41. Paulsson, K., & Johansson, B. (2009). High hyperdiploid childhood acute lymphoblastic leukemia. Genes, Chromosomes and Cancer, 48(8), 637–660.

    PubMed  Google Scholar 

  42. Nachman, J. B., Heerema, N. A., Sather, H., et al. (2007). Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood, 110(4), 1112–1115.

    PubMed Central  PubMed  Google Scholar 

  43. Heerema, N. A., Harbott, J., Galimberti, S., et al. (2004). Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia, 18(4), 693–702.

    PubMed  Google Scholar 

  44. Gaynon, P. S., Desai, A. A., Bostrom, B. C., et al. (1997). Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer, 80(9), 1717–1726.

    PubMed  Google Scholar 

  45. Lauten, M., Stanulla, M., Zimmermann, M., et al. (2001). Clinical outcome of patients with childhood acute lymphoblastic leukemia and an initial leukemic blood blast count of less than 1000 per microliter. Klinische Pädiatrie, 213(4), 169–174.

    PubMed  Google Scholar 

  46. Manabe, A., Ohara, A., Hasegawa, D., et al. (2008). Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: The Tokyo children’s cancer study group study L99-15. Haematologica, 93(8), 1155–1160.

    PubMed  Google Scholar 

  47. Griffin, T. C., Shuster, J. J., Buchanan, G. R., et al. (2000). Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: A pediatric oncology group study. Leukemia, 14(5), 792–795.

    PubMed  Google Scholar 

  48. Oudot, C., Auclerc, M. F., Levy, V., et al. (2008). Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: The FRALLE 93 study. Journal of Clinical Oncology, 26(9), 1496–1503.

    PubMed  Google Scholar 

  49. Borowitz, M. J., Devidas, M., Hunger, S. P., et al. (2008). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A children’s oncology group study. Blood, 111(12), 5477–5485.

    PubMed Central  PubMed  Google Scholar 

  50. National Cancer Institute. (2012). Accessed December 28, 2012, from http://www.cancer.gov/cancertopics/pdq/treatment/childALL/HealthProfessional/page4

  51. Schultz, K. R., Pullen, D. J., Sather, H. N., et al. (2007). Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the pediatric oncology group (POG) and children’s cancer group (CCG). Blood, 109(3), 926–935.

    PubMed Central  PubMed  Google Scholar 

  52. Hertzberg, H., Huk, W. J., Ueberall, M. A., et al. (1997). CNS late effects after ALL therapy in childhood. Part I. Neuroradiological findings in long-term survivors of childhood ALL: An evaluation of the interferences between morphology and neuropsychological performance—The German late effects working group. Medical and Pediatric Oncology, 28, 38–400.

    Google Scholar 

  53. Brown, R. T., & Madan-Swain, A. (1993). Cognitive, neuropsychological, and academic sequelae in children with leukemia. Journal of Learning Disabilities, 26(2), 74–90.

    PubMed  Google Scholar 

  54. Horton, T., & Steuber, C. (2011). Overview of the treatment of acute lymphoblastic leukemia in children. In D. S. Basow (Ed.), UpToDate. Waltham: UpToDate.

    Google Scholar 

  55. Pui, C. H., & Howard, S. C. (2008). Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncology, 9(3), 257–268.

    PubMed  Google Scholar 

  56. Dinndorf, P. A., Gootenberg, J., Cohen, M. H., et al. (2007). FDA drug approval summary: Pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). The Oncologist, 12, 991.

    PubMed  Google Scholar 

  57. Landau, H., & Lamanna, N. (2006). Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adults. Current Hematologic Malignancy Reports, 1, 171–179.

    PubMed  Google Scholar 

  58. Patte, C., Auperin, A., Michon, J., & Behrendt, H. (2001). The Société Française d’Oncologie Pédiatrique LMB89 protocol: Highly e! ective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 97, 3370–3379.

    PubMed  Google Scholar 

  59. Harris, M. B., Shuster, J. J., Pullen, D. J., Borowitz, M. J., Carroll, A. J., Behm, F. G., et al. (1998). Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: A pediatric oncology group study. Journal of Clinical Oncology, 16(8), 2840–2847.

    PubMed  Google Scholar 

  60. Lauer, S. J., Shuster, J. J., Mahoney, D. H., et al. (2001). A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A pediatric oncology group phase III randomized trial. Leukemia, 15(7), 1038–1045.

    PubMed  Google Scholar 

  61. Waber, D. P., & Mullenix, P. J. (2000). Acute lymphoblastic leukemia. In K. O. Yeates, D. M. Ris, & H. G. Taylor (Eds.), Pediatric neuropsychology: Research, theory, and practice. New York: The Guilford Press.

    Google Scholar 

  62. Janzen, L. A., & Spiegler, B. J. (2008). Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Developmental Disabilities Research Reviews, 14, 185–195.

    PubMed  Google Scholar 

  63. Geeta, M. G., Geetha, P., Ajithkumar, V. T., Krishnakumar, P., Kumar, K. S., & Mathews, L. (2010). Management of pain in leukemic children using the WHO analgesic ladder. Indian Journal of Pediatrics, 77(6), 665–668.

    PubMed  Google Scholar 

  64. Jankovic, M., Brouwers, P., Valsecchi, M. G., et al. (1994). Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukemia. ISPACC International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet, 344, 224–227.

    PubMed  Google Scholar 

  65. Mulhern, R. K., Khan, R. B., Kaplan, S., Helton, S., Christensen, R., Bonner, M., et al. (2004). Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. Journal of Clinical Oncology, 22(23), 4795–4803.

    PubMed  Google Scholar 

  66. Ciesielski, K. T., Yanofsky, R., Ludwig, R. N., et al. (1994). Hypoplasia of cerebellar vermis and cognitive deficits in survivors of childhood leukemia. Archives of Neurology (Chicago), 51, 985–993.

    Google Scholar 

  67. Moore, I. M., Kramer, J. H., Wara, W. W., Halberg, F., & Ablin, A. R. (1991). Cognitive function in children with leukemia: Effect of radiation dose and time since irradiation. Cancer, 68, 1913–1917.

    PubMed  Google Scholar 

  68. Campbell, L. K., Scaduto, M., & Sharp, W. (2007). A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatric Blood & Cancer, 49, 65–73.

    Google Scholar 

  69. Waber, D., Shapiro, B., Carpentieri, S., Gelber, R. D., Zou, G., Dufresne, A., et al. (2001). Minimal late neurotoxicity and excellent efficacy of therapy in children treated for acute lymphoblastic leukemia with 1800 cGy CRT: Seven-year follow-up of Dana-Farber cancer institute consortium protocol 87–001. Cancer, 92, 15–221.

    PubMed  Google Scholar 

  70. Carey, M. E. (2007). Brief report: Effect of intravenous MTX dose and infusion rate on neuropsychological function one year after diagnosis of ALL. Journal of Pediatric Psychology, 32(2), 189–193.

    PubMed  Google Scholar 

  71. Carey, M. E., Haut, M. W., Reminger, S. L., Hutter, J. J., Theilmann, R., & Keemingk, K. L. (2008). Reduced frontal white matter in long-term childhood leukemia survivors: A voxel-based morphometry study. American Journal of Neuroradiology, 29, 792–797.

    PubMed  Google Scholar 

  72. Eiser, C., & Tillman, V. (2001). Learning difficulties in children treated for acute lymphoblastic leukemia (ALL). Pediatric Rehabilitation, 3(4), 105–118.

    Google Scholar 

  73. Phillips, P. C., Dhawan, V., Strother, S. C., et al. (1987). Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: A positron emission tomographic study. Annals of Neurology, 21, 59–63.

    PubMed  Google Scholar 

  74. Mitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., & Eden, T. O. (2005). Benefit of dexamethasone vs. prednisone for childhood acute lymphoblastic leukemia: Results of the UK Medical Research Council ALL97 randomized trial. British Journal of Haematology, 129(6), 734–745.

    PubMed  Google Scholar 

  75. Waber, D. P., Carpentieri, S. C., Klar, N., et al. (2000). Cognitive Sequelae in children treated with dexamethasone or prednisone. Journal of Pediatric Hematology/Oncology, 22(3), 206–213.

    PubMed  Google Scholar 

  76. Bostrom, B. C., Sensel, M. R., Sather, H. N., et al. (2003). Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the children’s cancer group. Blood, 101(10), 3809–3817.

    PubMed  Google Scholar 

  77. Reddick, W. E., Shan, Z. Y., Glass, J. O., et al. (2006). Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer, 106, 941–949.

    PubMed Central  PubMed  Google Scholar 

  78. Iuvone, L., Mariotti, P., Colosimo, C., et al. (2002). Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer, 95, 2562–2570.

    PubMed  Google Scholar 

  79. Wilson, D. A., Nitschke, R., Bowman, M. E., et al. (1991). Transient white matter changes on MR imaged in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies. Radiology, 180, 205–209.

    PubMed  Google Scholar 

  80. Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603–630.

    PubMed  Google Scholar 

  81. Giralt, J., Ortega, J. J., Olive, T., Verges, R., Forio, I., & Salvador, L. (1992). Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens. International Journal of Radiation Oncology, 24, 49–53.

    Google Scholar 

  82. Langer, T., Martus, P., Ottensmeier, H., Hertzberg, H., Beck, J. D., & Meier, W. (2002). CNS late-effects after ALL therapy in childhood, part III: Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory. Medical and Pediatric Oncology, 38(5), 320–328.

    PubMed  Google Scholar 

  83. Lofstad, E., Reinjell, T., Hestad, K., & Diseth, T. (2009). Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Paediatrica, 98, 180–186.

    PubMed Central  PubMed  Google Scholar 

  84. Kingma, A., Van Dommelen, R. I., Mooyaart, E. L., et al. (2001). Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. Journal of Pediatrics, 139, 413–420.

    PubMed  Google Scholar 

  85. Halsey, C., Buck, G., Richards, S., Vargha-Khadem, F., Hill, F., & Gibson, B. (2011). The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. Journal of Hematology & Oncology, 4, 42.

    Google Scholar 

  86. Fletcher, J. M., & Copeland, D. R. (1988). Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. Journal of Clinical and Experimental Neuropsychology, 10, 495–538.

    PubMed  Google Scholar 

  87. Halberg, F. E., Kramer, J. H., Moore, I. M., Wara, W. M., Matthey, K. K., & Ablin, A. R. (1991). Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. International Journal of Radiation Oncology, 22, 13–16.

    Google Scholar 

  88. Rodgers, J., Britton, P. G., Kernahan, J., & Craft, A. W. (1991). Cognitive function after two doses of cranial irradiation for acute lymphoblastic leukaemia. Archives of Disease in Childhood, 66, 1245–1246.

    PubMed Central  PubMed  Google Scholar 

  89. Brown, R. T., Sawyer, M. B., Antoniou, G., et al. (1996). A 3-year follow-up of the intellectual and the academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. Journal of Developmental and Behavioral Pediatrics, 17, 392–398.

    PubMed  Google Scholar 

  90. Brown, R. R., Sawyer, M. B., Antoniou, G., et al. (1998). Longitudinal follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia: A four year final report. Journal of Developmental and Behavioral Pediatrics, 17, 392–398.

    Google Scholar 

  91. Kahallye, L. S., Conklin, H. M., Tyc, V. L., et al. (2011). ADHD and Secondary ADHD criteria fail to identify many at-risk survivors of pediatric ALL and Brain Tumor. Pediatric Blood & Cancer, 57, 110–118.

    Google Scholar 

  92. Alderson, R. M., & Mullins, L. L. (2011). Theoretical and clinical implications of using an ADHD framework to understand attention, concentration, and executive functioning deficits in pediatric cancer survivors. Pediatric Blood & Cancer, 57(1), 4–5.

    Google Scholar 

  93. Schatz, J., Kramer, J. H., Ablin, A., & Matthay, K. K. (2000). Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology, 14(2), 189–200.

    PubMed  Google Scholar 

  94. Conklin, H. M., Reddick, W. E., Ashford, J., et al. (2010). Long term of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. Journal of Clinical Oncology, 28(29), 4465–4472.

    PubMed Central  PubMed  Google Scholar 

  95. Mulhern, R. K., & Butler, R. W. (2004). Neurocognitive sequelae of childhood cancers and their treatment. Pediatric Rehabilitation, 7(1), 14.

    Google Scholar 

  96. Marchese, V. G., & Chiarello, L. A. (2004). Relationships between specific measures of body function, activity and participation in children with acute lymphoblastic leukemia. Rehabilitation Oncology, 22, 5–9.

    Google Scholar 

  97. Lehtinen, S. S., Huuskonen, U. E., Harila-Saari, A. H., et al. (2003). Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer, 94, 2466–2473.

    Google Scholar 

  98. Reinders-Messelink, H., Schoemaker, M., & Snijders, T. (1999). Motor performance of children during treatment for acute lymphoblasticleukemia. Medical and Pediatric Oncology, 33, 545–550.

    PubMed  Google Scholar 

  99. Copeland, D. R., Dowell, R. E., Fletcher, J. M., et al. (1988). Neuropsychological effects of childhood cancer treatment. Journal of Child Neurology, 3, 53–62.

    PubMed  Google Scholar 

  100. Copeland, D. R., Dowell, R. E., Fletcher, J. M., et al. (1988). Neuropsychological test performance of pediatric cancer patients at diagnosis and one year later. Journal of Pediatric Psychology, 13, 183–196.

    PubMed  Google Scholar 

  101. Copeland, D. R., Moore, B. D., Francis, D. J., Jaffe, N., & Culbert, S. J. (1996). Neuropsychologic effects of chemotherapy on children with cancer—A longitudinal study. Journal of Clinical Oncology, 14, 2826–2835.

    PubMed  Google Scholar 

  102. Dowell, R. E., Copeland, D. R., & Judd, B. W. (1989). Neuropsychological effects of chemotherapeutic agents. Developmental Neuropsychology, 5, 17–24.

    Google Scholar 

  103. Vainionpaa, L. (1993). Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment. European Journal of Pediatrics, 152, 115–119.

    PubMed  Google Scholar 

  104. Hockenberry, M., Krull, K., Moore, K., Gregurich, A., Casey, M., & Kaemingk, K. (2007). Longitudinal evaluation of fine motor skills in children with leukemia. Journal of Pediatric Hematology/Oncology, 29, 535–539.

    PubMed  Google Scholar 

  105. Robinson, K. E., Livesay, K. L., Campbell, L. K., et al. (2010). Working memory in survivors of childhood acute lymphocytic leukemia: Functional neuroimaging analyses. Pediatric Blood & Cancer, 54, 585–590.

    Google Scholar 

  106. Hill, D. E., Ciesielski, K. T., Hart, B. L., & Jung, R. E. (2004). MRI morphometric and neuropsychological correlates of long-term memory in survivors of childhood leukemia. Pediatric Blood & Cancer, 42(7), 611–617.

    Google Scholar 

  107. Waber, D. P., Isquith, P. K., & Kahn, C. N. (1994). Metacognitive factors in the visuospatial skills of long term survivors of acute lymphoblastic leukemia: An experimental approach to the Rey-Osterrieth complex figure test. Developmental Neuropsychology, 10, 349–367.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwest Behavioral Health Services, Arlington Heights, IL, USA

    Peter A. Dodzik Psy.D., A.B.Pd.N., A.B.P.N.

  2. Department of Neuropsychology, Fort Wayne Neurological Center, 11104 Parkview Circle, Suite 110, Fort Wayne, IN, 46845, USA

    Peter A. Dodzik Psy.D., A.B.Pd.N., A.B.P.N.

  3. Fort Wayne Neurological Center, 11104 Parkview Circle, Suite 110, Fort Wayne, IN, 46845, USA

    Randy Fulton Psy.D.

Authors
  1. Peter A. Dodzik Psy.D., A.B.Pd.N., A.B.P.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Randy Fulton Psy.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter A. Dodzik Psy.D., A.B.Pd.N., A.B.P.N. .

Editor information

Editors and Affiliations

  1. Department of Pediatric Psychology, CHOC Children’s Hospital, Neuropsychology Services, Orange, Newport Beach, California, USA

    Grace A. Mucci

  2. Division of Oncology, CHOC After Cancer Treatment Survivorship Program, CHOC Children’s Hospital, University of California, Irvine, Irvine, Orange, California, USA

    Lilibeth R. Torno

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer New York

About this chapter

Cite this chapter

Dodzik, P.A., Fulton, R. (2015). Neuropsychological Outcomes in Children with Acute Lymphoblastic Leukemia. In: Mucci, G., Torno, L. (eds) Handbook of Long Term Care of The Childhood Cancer Survivor. Specialty Topics in Pediatric Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7584-3_15

Download citation

Publish with us

Policies and ethics

Search

Navigation